Shafqat Areez, Albalkhi Ibrahem, Magableh Hamzah M, Saleh Tariq, Alkattan Khaled, Yaqinuddin Ahmed
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Front Cell Neurosci. 2023 May 24;17:1180825. doi: 10.3389/fncel.2023.1180825. eCollection 2023.
Axonal regeneration and functional recovery are poor after spinal cord injury (SCI), typified by the formation of an injury scar. While this scar was traditionally believed to be primarily responsible for axonal regeneration failure, current knowledge takes a more holistic approach that considers the intrinsic growth capacity of axons. Targeting the SCI scar has also not reproducibly yielded nearly the same efficacy in animal models compared to these neuron-directed approaches. These results suggest that the major reason behind central nervous system (CNS) regeneration failure is not the injury scar but a failure to stimulate axon growth adequately. These findings raise questions about whether targeting neuroinflammation and glial scarring still constitute viable translational avenues. We provide a comprehensive review of the dual role of neuroinflammation and scarring after SCI and how future research can produce therapeutic strategies targeting the hurdles to axonal regeneration posed by these processes without compromising neuroprotection.
脊髓损伤(SCI)后轴突再生和功能恢复较差,其典型特征是形成损伤瘢痕。虽然传统上认为这种瘢痕是轴突再生失败的主要原因,但目前的认识采用了更全面的方法,考虑了轴突的内在生长能力。与这些针对神经元的方法相比,针对SCI瘢痕在动物模型中也未能可重复地产生几乎相同的疗效。这些结果表明,中枢神经系统(CNS)再生失败的主要原因不是损伤瘢痕,而是未能充分刺激轴突生长。这些发现引发了关于针对神经炎症和胶质瘢痕形成是否仍然构成可行的转化途径的问题。我们全面综述了SCI后神经炎症和瘢痕形成的双重作用,以及未来研究如何在不损害神经保护的情况下制定针对这些过程给轴突再生带来障碍的治疗策略。